Can [125I]-iodocyanopindolol label β3-adrenoceptors in rat: Urinary bladder?

Frontiers in Pharmacology

Volumn OCT, Issue , 2010, Pages

  Schneider, Tim ^a,c   Michel, Martin Christian ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Praxisklinik Urologie Rhein Ruhr   (Germany)

Author keywords

3 adrenoceptor; 125I iodocyanopindolol; Lung; Rat; Urinary bladder

Indexed keywords

EID: 84865966801     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2010.00128     Document Type: Article

References (28)

1. Aizawa, N., Igawa, Y., Nishizawa, O., and Wyndaele, J.-J. (2010). Effects of CL316,243, a β3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol. Urodyn. 29, 771-776.
2. Baker, J. G. (2005). The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors. Br. J. Pharmacol. 144, 317-322.
3. Baker, J. G. (2010). The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors. Br. J. Pharmacol. 160, 1048-1061.
4. Barendrecht, M. M., Frazier, E. P., Vrydag, W., Alewijnse, A. E., Peters, S. L. M., and Michel, M. C. (2009). The effect of bladder outlet obstruction on α1- and β-adrenoceptor expression and function. Neurourol. Urodyn. 28, 349-355.
5. Cheng, Y.-C., and Prusoff, W. H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
6. Engel, G., Hoyer, D., Berthold, R., and Wagner, H. (1981). (±)[125Iodo] cyanopindolol, a new ligand for β-adrenoceptors: identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch. Pharmacol. 317, 277-285.
7. Fujimura, T., Tamura, K., Tsutsumi, T., Yamamoto, T., Nakamura, K., Koibuchi, Y., Kobayashi, M., and Yamaguchi, O. (1999). Expression and possible functional role of the β3-adrenoceptor in human and rat detrusor muscle. J. Urol. 161, 680-685.
8. Galindo-Tovar, A., Vargas, M. L., and Kaumann, A. J. (2009). Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium. Naunyn Schmiedebergs Arch. Pharmacol. 379, 379-384.
9. Goepel, M., Wittmann, A., Rübben, H., and Michel, M. C. (1997). Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol. Res. 25, 199-206.
10. Granneman, J. G., Lahners, K. N., and Chaudhry, A. (1991). Molecular cloning and expression of the rat β3-adrenergic receptor. Mol. Pharmacol. 40, 895-899.
11. Hoffmann, C., Leitz, M. R., Oberdorf-Maass, S., Lohse, M. J., and Klotz, K.-N. (2004). Comparative pharmacology of human β-adrenergic receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 369, 151-159.
12. Hoyer, D., Engel, G., and Kalkman, H. O. (1985). Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. Eur. J. Pharmacol. 118, 1-12.
13. Kaumann, A. J., and Molenaar, P. (2008). The low affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology. Pharmacol. Ther. 118, 303-336.
14. Leon, L. A., Hoffman, B. E., Gardner, S. D., Laping, N. J., Evans, C., Lashinger, E. S. R., and Su, X. (2008). Effects of the β3-adrenergic receptor agonist disodium 5[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl] amino]propyl]-1,3-benzodioxole-2-,2,dicarboxylate (L-316243) on bladder micturition reflex in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 326, 178-185.
15. Masunaga, K., Chapple, C. R., McKay, N. G., Yoshida, M., and Sellers, D. J. (2010). The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol. Urodyn. 29, 1320-1325.
16. Michel, M. C., Ochodnicky, P., and Summers, R. J. (2010). Tissue functions mediated by β3-adrenoceptors - findings and challenges. Naunyn Schmiedebergs Arch. Pharmacol. 382, 103-108.
17. Michel, M. C., and Vrydag, W. (2006). α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br. J. Pharmacol. 147, S88-S119.
18. Michel, M. C., Wang, X. L., Schlicker, E., Göthert, M., Beckeringh, J. J., and Brodde, O.-E. (1987). Increased β2-adrenoceptor density in heart, lung and kidney of spontaneously hypertensive rats. J. Auton. Pharmacol. 7, 41-51.
19. Minneman, K. P., Hegstrand, L. R., and Molinoff, P. B. (1979). Simultaneous determination of beta-1 and beta-2 adrenergic receptors in tissues containing both receptor subtypes. Mol. Pharmacol. 16, 34-46.
20. Mori, A., Miwa, T., Sakamoto, K., Nakahara, T., and Ishii, K. (2010). Pharmacological evidence for the presence of functional β3-adrenoceptors in rat retinal blood vessels. Naunyn Schmiedebergs Arch. Pharmacol. 382, 119-126.
21. Muzzin, P., Revelli, J.-P., Kuhne, F., Gocayne, J. D., McCombie, W. R., Venter, J. C., Giacobino, J.-P., and Fraser, C. M. (1991). An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 266, 24053-24058.
22. Niclauß, N., Michel-Reher, M. B., Alewijnse, A. E., and Michel, M. C. (2006). Comparison of three radioligands for the labelling of human β-adrenoceptor subtypes. Naunyn Schmiedebergs Arch. Pharmacol. 374, 79-85.
23. Otsuka, A., Shinbo, H., Matsumoto, R., Kurita, Y., and Ozono, S. (2008). Expression and functional role of β-adrenoceptors in the human urinary bladder. Naunyn Schmiedebergs Arch. Pharmacol. 377, 473-481.
24. Pradidarcheep, W., Stallen, J., Labruyere, W. T., Dabhoiwala, N. F., Michel, M. C., and Lamers, W. H. (2009). Lack of specificity of commercially available antisera against muscarinic and adrenergic receptors. Naunyn Schmiedebergs Arch. Pharmacol. 379, 397-402.
25. Roberts, S. J., Molenaar, P., and Summers, R. J. (1993). Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle. Br. J. Pharmacol. 109, 344-352.
26. Sugasawa, T., Matsuzaki-Fujita, M., Guillaume, J.-L., Camoin, L., Morooka, S., and Strosberg, A. D. (1997). Characterization of a novel iodocyanopindolol and SM-11044 binding protein, which may mediate relaxation of depolarized rat colon tonus. J. Biol. Chem. 272, 21244-21252.
27. Vrydag, W., Alewijnse, A. E., and Michel, M. C. (2009). Do gene polymorphisms alone or in combination affect the function of human β3-adrenoceptors? Br. J. Pharmacol. 156, 127-134.
28. Vrydag, W., and Michel, M. C. (2007). Tools to study β3-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 374, 385-398.